DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Decreased Appetite - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Decreased Appetite (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include decreased appetite. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Hydrocortisone side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: 77 year old female

Reactions: Epstein-Barr Virus Infection, Pneumocystis Jiroveci Pneumonia, Lung Disorder, Rheumatoid Lung, Asthenia, Immunosuppression, Epistaxis, Decreased Appetite, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Enbrel
    Dosage: 50 mg, weekly
    Indication: Rheumatoid Arthritis
    Start date: 2010-11-01
    End date: 2012-04-01

Methotrexate Sodium
    Dosage: 6 df, weekly
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2010-10-01
    End date: 2012-04-01

Hydrocortisone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2010-10-01

Other drugs received by patient: Citalopram Hydrobromide; Levothyroxine Sodium; Leucovorin Calcium; Pravastatin; Omeprazole; Enalapril Maleate; Amlodipine Besylate; Ferrous Sulfate TAB; Aspirin; Duphalac; Acetaminophen



Possible Hydrocortisone side effects in 77 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09

Patient: 77 year old female

Reactions: Epstein-Barr Virus Infection, Pneumocystis Jiroveci Pneumonia, Lung Disorder, Rheumatoid Lung, Asthenia, Decreased Appetite, Immunosuppression, Epistaxis, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate Sodium
    Dosage: 6 df, weekly
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2010-10-01
    End date: 2012-04-01

Hydrocortisone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2010-10-01

Enbrel
    Dosage: 50 mg, weekly
    Indication: Rheumatoid Arthritis
    Start date: 2010-10-01
    End date: 2012-04-01

Other drugs received by patient: Omeprazole; Leucovorin Calcium; Duphalac; Levothyroxine Sodium; Pravastatin; Ferrous Sulfate TAB; Enalapril Maleate; Amlodipine Besylate; Citalopram Hydrobromide; Aspirin; Acetaminophen



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05

Patient: 10 year old female

Reactions: Cushingoid, Abdominal Pain, Coagulopathy, Hyponatraemia, Hyperviscosity Syndrome, Headache, Pallor, Somnolence, Hepatic Enzyme Increased, Malaise, Nervous System Disorder, Oedema, Asthenia, Hypertriglyceridaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: 8 mg/m2, per day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: 30 mg, unk
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 10000 iu/m2, per day
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Epirubicin; Methotrexate; Cytarabine; Daunorubicin HCL; Methotrexate W / Cytarabine / Hydrocortisone; Vincristine; Cyclophosphamide; Mercaptopurine



Possible Hydrocortisone side effects in 2 month old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-17

Patient: 2 month old male, weighing 3.0 kg (6.6 pounds)

Reactions: Developmental Delay, Neoplasm Malignant, Growth Retardation, Gynaecomastia, Decreased Appetite

Drug(s) suspected as cause:
Mitotane
    Dosage: increased to 2, then 2.5 g/day discontinued at 18 months
    Indication: Adrenal Gland Cancer Metastatic

Fludrocortisone Acetate

Hydrocortisone



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-04-30

Patient: male

Reactions: Off Label Use, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Prostate Cancer Metastatic

Hydrocortisone
    Dosage: tapering dose after 3 weeks

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-04-30

Patient: male

Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Mucosal Inflammation, Dysgeusia, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Prostate Cancer Metastatic

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist



Possible Hydrocortisone side effects in 20 year old female

Reported by a consumer/non-health professional from United States on 2012-03-27

Patient: 20 year old female, weighing 74.8 kg (164.6 pounds)

Reactions: Oropharyngeal Pain, Arthralgia, Arthritis Infective, Oesophagitis, Blood Culture Positive, Hypoxia, Colitis, Joint Effusion, Sinusitis, Decreased Appetite, Pharyngitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 30 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-27

Methotrexate
    Dosage: 500 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-24

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17

Cyclophosphamide
    Dosage: 440 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Hydrocortisone
    Dosage: 15 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-27

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17

Pegaspargase
    Dosage: 2500 unk, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-14

Methotrexate
    Dosage: 4500 mg/m2, unk



Possible Hydrocortisone side effects in 20 year old female

Reported by a consumer/non-health professional from United States on 2012-03-16

Patient: 20 year old female, weighing 74.8 kg (164.6 pounds)

Reactions: Oropharyngeal Pain, Culture Stool Positive, Oesophagitis, Chest Pain, Blood Culture Positive, Hypoxia, Joint Effusion, Cholecystitis, Sinusitis, Pharyngitis, Decreased Appetite, Helicobacter Infection, Arthralgia, Arthritis Infective, Colitis, Sleep Apnoea Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 30 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-27

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17

Methotrexate
    Dosage: 4500 mg/m2, unk

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-14

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Hydrocortisone
    Dosage: 15 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-27

Methotrexate
    Dosage: 500 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-24

Pegaspargase
    Dosage: 2500 unk, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Cyclophosphamide
    Dosage: 440 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-28

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-03-02

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-03-07

Patient: male

Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Dysgeusia, Mucosal Inflammation, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Prostate Cancer Metastatic

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist



Possible Hydrocortisone side effects in 20 year old female

Reported by a physician from United States on 2012-03-01

Patient: 20 year old female, weighing 86.6 kg (190.5 pounds)

Reactions: Oropharyngeal Pain, Arthralgia, Oesophagitis, Arthritis Infective, Blood Culture Positive, Colitis, Joint Effusion, Decreased Appetite, Pharyngitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17

Hydrocortisone
    Dosage: unk mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-27

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Pegaspargase
    Dosage: 2500 unk, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-04

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07



Possible Hydrocortisone side effects in 20 year old female

Reported by a consumer/non-health professional from United States on 2012-02-20

Patient: 20 year old female, weighing 86.6 kg (190.5 pounds)

Reactions: Oesophagitis, Blood Culture Positive, Colitis, Oropharyngeal Pain, Pharyngitis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-04

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-27

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Hydrocortisone
    Dosage: unk mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Pegaspargase
    Dosage: 2500 unk, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-02-07

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-01-16
    End date: 2012-01-17



Possible Hydrocortisone side effects in male

Reported by a physician from United States on 2012-01-31

Patient: male

Reactions: Off Label Use, Decreased Appetite

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: tapering dose after 3 weeks

Ketoconazole
    Administration route: Oral
    Indication: Prostate Cancer Metastatic

Hydrocortisone
    Indication: Prostate Cancer Metastatic

Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017